| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b4beef0c137d9094e6918ee382be22f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate |
1987-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1988-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5763a30fa61fe6f1eaacd8a375d43b36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddc0885f8debdbf705e4132c339d8cc1 |
| publicationDate |
1988-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4766127-A |
| titleOfInvention |
2-(3-pyridylmethyl)naphthalene-6-carboxylic acid as a thromboxane synthetase inhibitor |
| abstract |
The invention concerns a method of inhibiting thromboxane synthetase with a compound of the formula: <IMAGE> (I) or a pharmaceutically acceptable salt or ester thereof, in a mammal having a disease characterized by elevated thromboxane levels or an imbalance of prostacyclinthromboxane levels. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-4546589-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000007658-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4942171-A |
| priorityDate |
1987-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |